It's not difficult to produce PPS. What's difficult is producing the exact type of PPS that PAR uses.
- Forums
- ASX - By Stock
- PAR
- Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.83%
!
41.8¢

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-205
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.8¢ |
Change
0.008(1.83%) |
Mkt cap ! $162.9M |
Open | High | Low | Value | Volume |
40.0¢ | 41.8¢ | 40.0¢ | $105.0K | 259.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1462 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 55654 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4347 | 0.410 |
3 | 12491 | 0.405 |
7 | 26686 | 0.400 |
8 | 149464 | 0.395 |
6 | 106650 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 51400 | 2 |
0.425 | 16695 | 7 |
0.430 | 36032 | 5 |
0.440 | 54272 | 5 |
0.445 | 25700 | 5 |
Last trade - 13.35pm 18/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |